Chemical inhibitors of Afamin can interfere with its ability to bind and transport vitamin E, a critical function of the protein. Warfarin and Dicoumarol, known for their anticoagulant properties, exhibit structural similarities to vitamin K and by extension can have some competitive affinity towards vitamin E binding sites. This competition can inhibit Afamin's capacity to bind vitamin E, thus impeding its transport role. Similarly, Vitamin K3, through its structural analogy with vitamin E, can occupy the binding sites on Afamin, leading to an inhibition of the Afamin-vitamin E interaction. This competitive binding mechanism can prevent the proper functioning of Afamin in vitamin E transport. Probucol, an antioxidant with structural features akin to vitamin E, also has the potential to compete with vitamin E for binding sites on Afamin, thereby inhibiting its normal function. Tocopherol Succinate, a derivative of vitamin E itself, can bind to Afamin, which may result in the inhibition of Afamin's interaction with other forms of vitamin E due to competitive inhibition.
In addition to these direct competitors, other chemicals can indirectly influence Afamin's function by affecting the lipid environment in which it operates. Atorvastatin, though primarily focused on cholesterol synthesis, could influence lipoprotein levels and indirectly disrupt the transport dynamics of vitamin E, thus affecting Afamin's role. Cholestyramine's binding of bile acids can alter the enterohepatic recycling of lipids, which might reduce the functional requirement for Afamin in vitamin E transport. Orlistat, by inhibiting lipases, can decrease the overall absorption of fat-soluble vitamins, such as vitamin E, thus reducing the substrate availability for Afamin. Ezetimibe, which impedes cholesterol absorption, might also incidentally decrease vitamin E absorption, further diminishing the need for Afamin's transport function. The presence of Vitamin A (Retinol) might also pose competitive inhibition to Afamin due to its role in the transport of fat-soluble vitamins. Lastly, compounds like Sesamin and Alpha-Lipoic Acid, which interfere with the metabolism and regeneration of vitamin E, could disrupt the equilibrium of vitamin E, indirectly inhibiting the transport function of Afamin by altering the concentrations of vitamin E available for binding and transport.
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Warfarin | 81-81-2 | sc-205888 sc-205888A | 1 g 10 g | $73.00 $246.00 | 7 | |
Warfarin competes with vitamin K and structurally similar compounds such as vitamin E for binding sites on transport proteins, potentially inhibiting Afamin's vitamin E binding capability. | ||||||
Dicoumarol | 66-76-2 | sc-205647 sc-205647A | 500 mg 5 g | $20.00 $40.00 | 8 | |
Dicoumarol, similar to warfarin, may interfere with vitamin E transport by competing for binding sites on proteins like Afamin, potentially inhibiting its function. | ||||||
Vitamin K3 | 58-27-5 | sc-205990B sc-205990 sc-205990A sc-205990C sc-205990D | 5 g 10 g 25 g 100 g 500 g | $26.00 $36.00 $47.00 $136.00 $455.00 | 3 | |
Menadione could potentially disrupt the vitamin E transport process by competitively inhibiting Afamin's binding sites due to structural similarity. | ||||||
Atorvastatin | 134523-00-5 | sc-337542A sc-337542 | 50 mg 100 mg | $257.00 $505.00 | 9 | |
Atorvastatin, while primarily affecting cholesterol synthesis, could theoretically alter lipoprotein transport and indirectly affect Afamin's function in vitamin E transport. | ||||||
Probucol | 23288-49-5 | sc-203666 sc-203666A | 100 mg 1 g | $79.00 $166.00 | 5 | |
Probucol, an antioxidant similar to vitamin E, might competitively inhibit Afamin's binding of vitamin E, thus interfering with its transport function. | ||||||
CHOLESTYRAMINE RESIN | 11041-12-6 | sc-507509 | 5 g | $210.00 | ||
Cholestyramine binds bile acids and could indirectly affect vitamin E levels by disrupting enterohepatic recycling, potentially affecting Afamin function. | ||||||
Lipase Inhibitor, THL | 96829-58-2 | sc-203108 | 50 mg | $52.00 | 7 | |
Orlistat inhibits lipase and could reduce the absorption of fat-soluble vitamins like vitamin E, potentially reducing the functional demand on Afamin. | ||||||
Ezetimibe | 163222-33-1 | sc-205690 sc-205690A | 25 mg 100 mg | $96.00 $241.00 | 12 | |
Ezetimibe reduces cholesterol absorption; this might indirectly decrease vitamin E absorption and reduce Afamin's role in vitamin E transport. | ||||||
Vitamin A | 68-26-8 | sc-280187 sc-280187A | 1 g 10 g | $385.00 $2654.00 | ||
Retinol might competitively inhibit vitamin E transport by Afamin due to its role in the transport of fat-soluble vitamins. | ||||||
α-Lipoic Acid | 1077-28-7 | sc-202032 sc-202032A sc-202032B sc-202032C sc-202032D | 5 g 10 g 250 g 500 g 1 kg | $69.00 $122.00 $212.00 $380.00 $716.00 | 3 | |
Alpha-Lipoic Acid may affect vitamin E regeneration and thus could alter the metabolic balance of vitamin E, indirectly inhibiting Afamin's transport function. | ||||||